Letter to the Editor regarding: "Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary" by R. Rosenberg et al.
作者信息
Roth Thomas
机构信息
Sleep Disorders and Research Center, Henry Ford Health System, Detroit, MI, USA.
出版信息
Neurol Ther. 2024 Aug;13(4):1303-1305. doi: 10.1007/s40120-024-00613-w. Epub 2024 May 25.
Abstract
摘要
相似文献
1
Letter to the Editor regarding: "Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary" by R. Rosenberg et al.致编辑的信：关于R. 罗森伯格等人所著的《发作性睡病患者中羟丁酸钠给药方案对睡眠、睡眠结构及夜间睡眠中断的影响：一篇评论》
Neurol Ther. 2024 Aug;13(4):1303-1305. doi: 10.1007/s40120-024-00613-w. Epub 2024 May 25.
2
Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.羟丁酸钠给药方案对发作性睡病患者睡眠、睡眠结构及夜间睡眠中断的影响：一篇评论
Neurol Ther. 2023 Dec;12(6):1805-1820. doi: 10.1007/s40120-023-00543-z. Epub 2023 Sep 27.
3
Effects of oxybate dose and regimen on disrupted nighttime sleep and sleep architecture.奥昔布宁剂量和方案对夜间睡眠和睡眠结构紊乱的影响。
Sleep Med. 2024 Feb;114:255-265. doi: 10.1016/j.sleep.2023.12.015. Epub 2023 Dec 24.
4
Response to Letter to the Editor Regarding "Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients With Narcolepsy: A Commentary".对致编辑信的回复，信的内容涉及“羟丁酸钠给药方案对发作性睡病患者睡眠、睡眠结构及夜间睡眠中断的影响：一篇评论”
Neurol Ther. 2024 Aug;13(4):1307-1311. doi: 10.1007/s40120-024-00611-y. Epub 2024 May 25.
5
Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary.富马酸替扎尼定（FT218）每晚一次给药可改善发作性睡病患者夜间睡眠中断症状：通俗易懂的总结。
J Comp Eff Res. 2023 Dec;12(12):e230133. doi: 10.57264/cer-2023-0133. Epub 2023 Nov 16.
6
Correction: Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.更正：羟丁酸钠给药方案对发作性睡病患者睡眠、睡眠结构及夜间睡眠中断的影响：一篇评论
Neurol Ther. 2024 Aug;13(4):1315-1319. doi: 10.1007/s40120-024-00606-9.
7
Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy.羟丁酸钠对发作性睡病患者夜间睡眠紊乱的影响。
J Sleep Res. 2017 Aug;26(4):407-414. doi: 10.1111/jsr.12468. Epub 2016 Nov 3.
8
Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial.苯海拉明（FT218）每晚一次治疗 1 型和 2 型发作性睡病的疗效：来自 3 期 REST-ON 试验的事后分析。
Sleep. 2023 Nov 8;46(11). doi: 10.1093/sleep/zsad152.
9
The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.每晚服用羟丁酸钠可显著减少发作性睡病患者的夜间睡眠中断情况。
Sleep Med. 2009 Sep;10(8):829-35. doi: 10.1016/j.sleep.2009.05.004. Epub 2009 Jul 18.
10
Effect of sodium oxybate, modafinil, and their combination on disrupted nighttime sleep in narcolepsy.羟丁酸钠、莫达非尼及其联合应用对发作性睡病患者夜间睡眠紊乱的影响。
Sleep Med. 2017 Dec;40:53-57. doi: 10.1016/j.sleep.2017.07.030. Epub 2017 Oct 7.
引用本文的文献
1
Response to Letter to the Editor Regarding "Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients With Narcolepsy: A Commentary".对致编辑信的回复，信的内容涉及“羟丁酸钠给药方案对发作性睡病患者睡眠、睡眠结构及夜间睡眠中断的影响：一篇评论”
Neurol Ther. 2024 Aug;13(4):1307-1311. doi: 10.1007/s40120-024-00611-y. Epub 2024 May 25.
本文引用的文献
1
Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.羟丁酸钠给药方案对发作性睡病患者睡眠、睡眠结构及夜间睡眠中断的影响：一篇评论
Neurol Ther. 2023 Dec;12(6):1805-1820. doi: 10.1007/s40120-023-00543-z. Epub 2023 Sep 27.
2
Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers.FT218（一种每晚一次的羟丁酸钠制剂）的相对生物利用度和安全性的随机、交叉、开放标签研究：健康志愿者的 1 期研究。
Sleep Med. 2022 Dec;100:442-447. doi: 10.1016/j.sleep.2022.09.011. Epub 2022 Sep 21.
3
Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial.FT218（一种每晚一次的羟丁酸钠制剂）对发作性睡病患者夜间睡眠中断的影响：来自随机 III 期 REST-ON 试验的结果。
CNS Drugs. 2022 Apr;36(4):377-387. doi: 10.1007/s40263-022-00904-6. Epub 2022 Apr 5.
4
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.在一项针对发作性睡病患者的 3 期随机临床试验中，每晚一次的羟丁酸钠（FT218）改善了症状。
Sleep. 2022 Jun 13;45(6). doi: 10.1093/sleep/zsab200.
5
Sleep inertia: current insights.睡眠惰性：当前见解
Nat Sci Sleep. 2019 Aug 22;11:155-165. doi: 10.2147/NSS.S188911. eCollection 2019.
6
Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.小儿发作性睡病用羟丁酸钠治疗：一项双盲、安慰剂对照、随机撤药多中心研究和开放性研究。
Lancet Child Adolesc Health. 2018 Jul;2(7):483-494. doi: 10.1016/S2352-4642(18)30133-0. Epub 2018 May 21.
Zotero 插件